Case Report: A Case of Glioblastoma in a Patient With Haberland Syndrome
Haberland syndrome or encephalocraniocutaneous lipomatosis is a rare ectomesodermal dysgenesis defined by the triad including ocular, skin, and central nervous system involvement, which is commonly unilateral. This disorder is attributed to a post-zygotic mutation responsible for a neural tube and n...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2021.648717/full |
_version_ | 1829503599186542592 |
---|---|
author | Silvia Ferranti Iacopo Sardi Milena Guidi Chiara Lembo Salvatore Grosso |
author_facet | Silvia Ferranti Iacopo Sardi Milena Guidi Chiara Lembo Salvatore Grosso |
author_sort | Silvia Ferranti |
collection | DOAJ |
description | Haberland syndrome or encephalocraniocutaneous lipomatosis is a rare ectomesodermal dysgenesis defined by the triad including ocular, skin, and central nervous system involvement, which is commonly unilateral. This disorder is attributed to a post-zygotic mutation responsible for a neural tube and neural crest dysgenesis. We report the case of a 15-year-old female with Haberland syndrome with pharmacoresistant epilepsy who developed a World Health Organization-grade IV glioblastoma. This is the first case of pediatric glioblastoma associated with Haberland syndrome. The previously reported pediatric cases included benign brain tumors. To our knowledge, this is the fifth case of brain tumor associated with encephalocraniocutaneous lipomatosis and the second case of glioblastoma associated with this syndrome. The hypothesis that Haberland syndrome is associated with an increased risk of tumor development is intriguing, although the rarity of the condition is nowadays preventing us from drawing definitive conclusions about this potential link between the two entities. Further studies are needed to establish the real relationship between encephalocraniocutaneous lipomatosis and the risk of brain tumors. |
first_indexed | 2024-12-16T10:01:17Z |
format | Article |
id | doaj.art-b199fa03c9e74f73ba056d93aaa499dd |
institution | Directory Open Access Journal |
issn | 2296-2360 |
language | English |
last_indexed | 2024-12-16T10:01:17Z |
publishDate | 2021-03-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Pediatrics |
spelling | doaj.art-b199fa03c9e74f73ba056d93aaa499dd2022-12-21T22:35:46ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602021-03-01910.3389/fped.2021.648717648717Case Report: A Case of Glioblastoma in a Patient With Haberland SyndromeSilvia Ferranti0Iacopo Sardi1Milena Guidi2Chiara Lembo3Salvatore Grosso4Department of Molecular Medicine and Development, University of Siena, Siena, ItalyDepartment of Pediatric Oncology, Meyer Children's Hospital, Florence, ItalyDepartment of Pediatric Oncology, Meyer Children's Hospital, Florence, ItalyDepartment of Molecular Medicine and Development, University of Siena, Siena, ItalyDepartment of Molecular Medicine and Development, University of Siena, Siena, ItalyHaberland syndrome or encephalocraniocutaneous lipomatosis is a rare ectomesodermal dysgenesis defined by the triad including ocular, skin, and central nervous system involvement, which is commonly unilateral. This disorder is attributed to a post-zygotic mutation responsible for a neural tube and neural crest dysgenesis. We report the case of a 15-year-old female with Haberland syndrome with pharmacoresistant epilepsy who developed a World Health Organization-grade IV glioblastoma. This is the first case of pediatric glioblastoma associated with Haberland syndrome. The previously reported pediatric cases included benign brain tumors. To our knowledge, this is the fifth case of brain tumor associated with encephalocraniocutaneous lipomatosis and the second case of glioblastoma associated with this syndrome. The hypothesis that Haberland syndrome is associated with an increased risk of tumor development is intriguing, although the rarity of the condition is nowadays preventing us from drawing definitive conclusions about this potential link between the two entities. Further studies are needed to establish the real relationship between encephalocraniocutaneous lipomatosis and the risk of brain tumors.https://www.frontiersin.org/articles/10.3389/fped.2021.648717/fullHaberland syndromeencephalocraniocutaneous lipomatosisglioblastomatumorepilepsy |
spellingShingle | Silvia Ferranti Iacopo Sardi Milena Guidi Chiara Lembo Salvatore Grosso Case Report: A Case of Glioblastoma in a Patient With Haberland Syndrome Frontiers in Pediatrics Haberland syndrome encephalocraniocutaneous lipomatosis glioblastoma tumor epilepsy |
title | Case Report: A Case of Glioblastoma in a Patient With Haberland Syndrome |
title_full | Case Report: A Case of Glioblastoma in a Patient With Haberland Syndrome |
title_fullStr | Case Report: A Case of Glioblastoma in a Patient With Haberland Syndrome |
title_full_unstemmed | Case Report: A Case of Glioblastoma in a Patient With Haberland Syndrome |
title_short | Case Report: A Case of Glioblastoma in a Patient With Haberland Syndrome |
title_sort | case report a case of glioblastoma in a patient with haberland syndrome |
topic | Haberland syndrome encephalocraniocutaneous lipomatosis glioblastoma tumor epilepsy |
url | https://www.frontiersin.org/articles/10.3389/fped.2021.648717/full |
work_keys_str_mv | AT silviaferranti casereportacaseofglioblastomainapatientwithhaberlandsyndrome AT iacoposardi casereportacaseofglioblastomainapatientwithhaberlandsyndrome AT milenaguidi casereportacaseofglioblastomainapatientwithhaberlandsyndrome AT chiaralembo casereportacaseofglioblastomainapatientwithhaberlandsyndrome AT salvatoregrosso casereportacaseofglioblastomainapatientwithhaberlandsyndrome |